Live Analyst Rating Changes 8035 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Jayson Bedford
RJ
Jayson Bedford
Raymond James
Wall Street Analyst
★★☆☆☆
#1962
on 13Foresight · ranked by our own returns
54%
Success Rate
+5.4%
Average Return
15 of 28 calls profitable · -7.1% vs benchmark
📈 Across the calls we could measure, roughly 54% of Jayson Bedford's ratings turned a profit when each position was held for 1 year — averaging +5.4% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

28 Buy 5 Hold 1 Sell
Jayson's Stock Coverage 23 ratings · 2026-07-14
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
PODD
Insulet
 Jun 08, 2026 BUY Strong Buy
+58.9% avg upside
32 analysts
$216.00
32.54% Upside
 +6.5%
DXCM
Dexcom
 Jun 08, 2026 BUY Strong Buy
+32.4% avg upside
32 analysts
$91.00
20.32% Upside
 -2.2%
TFX
Teleflex
 May 08, 2026 BUY Buy
+30.5% avg upside
20 analysts
$150.00
9.99% Upside
 +0.2%
MMSI
Merit Medical Systems
 May 01, 2026 BUY Strong Buy
+23.7% avg upside
15 analysts
$83.00
12.83% Upside
 +15.2%
AXGN
AxoGen
 Apr 29, 2026 BUY Strong Buy
-15.3% avg upside
21 analysts
$48.00
18.93% Upside
 -2.9%
BSX
Boston Scientific
 Mar 27, 2026 BUY Strong Buy
+68.6% avg upside
38 analysts
$88.00
96.53% Upside
 -35.4%
SYK
Stryker
 Jan 06, 2026 BUY Strong Buy
+13.8% avg upside
37 analysts
$418.00
25.49% Upside
 -9.5%
ZBH
Zimmer Biomet Holdings
 Jan 06, 2026 HOLD Buy
+19.2% avg upside
38 analysts
 — -3.1%
EW
Edwards Lifesciences
 Nov 03, 2025 BUY Strong Buy
+7.4% avg upside
34 analysts
$96.00
4.30% Upside
 +10.5%
ISRG
Intuitive Surgical
 Oct 22, 2025 BUY Strong Buy
+28.5% avg upside
36 analysts
$603.00
47.05% Upside
 -22.8%
CBLL
Ceribell, Inc.
 Oct 20, 2025 BUY Strong Buy
+27.2% avg upside
8 analysts
$19.00
4.12% Downside
 +56.5%
ABT
Abbott Laboratories
 Oct 16, 2025 BUY Strong Buy
+26.1% avg upside
36 analysts
$146.00
58.04% Upside
 -25.6%
JNJ
Johnson & Johnson
 Oct 15, 2025 BUY Strong Buy
-13.2% avg upside
36 analysts
$209.00
18.75% Downside
 +36.8%
MDT
Medtronic
 Aug 18, 2025 HOLD Buy
+15.8% avg upside
38 analysts
 — -7.0%
SENS
Senseonics Holdings
 Aug 08, 2025 SELL Strong Buy
+187.1% avg upside
13 analysts
 — +41.7%
ICUI
ICU Medical
 Aug 08, 2025 BUY Strong Buy
+4.6% avg upside
9 analysts
$180.00
14.54% Upside
 +34.6%
BAX
Baxter International
 Aug 01, 2025 HOLD Hold
+31.9% avg upside
23 analysts
 — +3.9%
IART
Integra Lifesciences
 Aug 01, 2025 HOLD Buy
+126.6% avg upside
21 analysts
 — +43.7%
BDX
Becton Dickinson
 May 02, 2025 HOLD Buy
+27.0% avg upside
25 analysts
 — +15.2%
BWAY
Brainsway
 Nov 16, 2023 HOLD Strong Buy
-8.6% avg upside
9 analysts
 — +95.3%
TNDM
Tandem Diabetes Care
 May 04, 2023 HOLD Buy
+104.2% avg upside
29 analysts
 — +19.2%
ANGO
AngioDynamics
 Apr 17, 2023 BUY Strong Buy
+32.6% avg upside
9 analysts
$13.00
0.60% Upside
 -30.3%
VIVE
Viveve Medical
 Jul 23, 2019 HOLD Buy
+79999900.1% avg upside
8 analysts
 — -96.3%
🔒 18 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Jayson Bedford — Frequently Asked Questions
How accurate are Jayson Bedford's stock ratings?
Based on the calls 13Foresight could measure, about 54% of Jayson's ratings were profitable over a one-year hold, with an average return of +5.4% per rating, or -7.2% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Jayson ranked on 13Foresight?
Jayson Bedford is currently ranked #1962 with a 2-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Jayson cover?
Jayson most recently has ratings on PODD, DXCM, TFX, MMSI, AXGN, BSX, SYK, ZBH, EW, ISRG, CBLL, ABT and 11 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.